尼克-4:在癌症中是一个有前途的预后标记物和治疗点
Shilpa Kuttikrishnan1, Kirti S Prabhu1, Ummu Habeeba1
1Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
International review of cell and molecular biology
|February 12, 2025
概括
结核细胞粘附蛋白4 (Nectin-4) 在许多癌症中过度表达,使其成为诊断和治疗的目标. 研究探讨了它在癌症进展和新疗法中的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 结核细胞粘附蛋白4 (Nectin-4) 是一种类似免疫球蛋白的蛋白质,在各种恶性瘤中过度表达,但在健康的成年组织中不存在.
- 升高的Nectin-4水平与肺癌,乳腺癌和泌尿器癌的发病有关.
- 尼克-4作为早期癌症诊断和疾病监测的血清学标记物具有前途.
研究的目的:
- 为了研究Nectin-4在癌症中的分子功能.
- 强调Nectin-4在瘤学中的诊断和预后价值.
- 探索新的治疗药物和正在进行的针对Nectin-4的临床试验.
主要方法:
- 关于Nectin-4在癌症发病过程中的作用的文献综述.
- 对Nectin-4的诊断和预后意义的分析.
- 目前和新兴的Nectin-4向疗法和临床试验的概述.
主要成果:
- 过度表达nectin-4是几种癌症的标志,与疾病进展相关.
- 恩福图马布维多丁 (EV) 是一种针对尼克-4的抗体-药物结合体,经FDA批准用于尿路细胞癌.
- 目前正在进行的研究正在扩大治疗应用,并调查针对Nectin-4的新药.
结论:
- 尼克-4是瘤学的关键标,具有显著的诊断和治疗潜力.
- 了解Nectin-4的分子机制对于改善临床结果至关重要.
- 进一步的研究和临床试验对于克服药物耐药性和不良影响等挑战至关重要.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


